RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
Several stocks are moving significantly in Monday's pre-market session. RXO, Inc. (NYSE:RXO) shares rose sharply after announcing the acquisition of Coyote Logistics from United Parcel Service, Inc. (NYSE:UPS). Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares surged following positive Phase 3 study results. Other notable gainers include Altimmune, Inc. (NASDAQ:ALT), Clover Health Investments, Corp. (NASDAQ:CLOV), argenx SE (NASDAQ:ARGX), Intellia Therapeutics, Inc. (NASDAQ:NTLA), Pharming Group N.V. (NASDAQ:PHAR), and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS).
June 24, 2024 | 11:54 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
United Parcel Service, Inc. is selling Coyote Logistics to RXO for $1.025 billion, which may impact its logistics operations and financials.
The sale of Coyote Logistics could streamline UPS's operations but may also reduce its logistics service offerings, leading to a neutral short-term impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Alnylam Pharmaceuticals, Inc. shares surged 38.8% after announcing positive topline results from its HELIOS-B Phase 3 study of vutrisiran.
Positive Phase 3 study results are a major milestone for Alnylam, significantly boosting investor confidence and driving the stock price higher.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100
POSITIVE IMPACT
Altimmune, Inc. shares gained 10.9% after presenting data from its 48-week Phase 2 MOMENTUM clinical trial of pemvidutide.
The positive clinical trial data presentation is likely to enhance investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
argenx SE shares gained 9.9% after announcing FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy.
FDA approval is a significant milestone, likely to drive investor optimism and boost the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 90
POSITIVE IMPACT
Clover Health Investments, Corp. shares gained 9.6% in pre-market trading after a significant gain on Friday.
The continued upward momentum suggests strong investor interest and confidence in Clover Health's prospects.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Ionis Pharmaceuticals, Inc. shares gained 5.2% in pre-market trading.
The stock's upward movement indicates positive investor sentiment, though specific catalysts are not mentioned.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Intellia Therapeutics, Inc. shares gained 9.5% in pre-market trading.
The stock's upward movement suggests positive investor sentiment, though specific catalysts are not mentioned.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Pharming Group N.V. shares gained 8.1% in pre-market trading after a decline on Friday.
The rebound suggests a recovery in investor confidence following the previous decline.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
RXO, Inc. shares rose 13.3% in pre-market trading after announcing the acquisition of Coyote Logistics from United Parcel Service for $1.025 billion.
The acquisition is a significant strategic move for RXO, likely to enhance its logistics capabilities and market position, driving investor optimism.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100